AKT1 and leukemia: THC, via CB1R activation, inhibited both PI3K/Akt and RAS-MAPK/ERK survival pathways in colorectal carcinoma cell lines, as well as in human Jurkat leukemia T cells, THC inhibited ERK, and Akt signaling.